Dantrolene as a possible prophylactic treatment for RYR1-related rhabdomyolysis

R S Scalco; N C Voermans; R J Piercy; H Jungbluth; R Quinlivan

doi:10.1111/ene.13051

Dantrolene as a possible prophylactic treatment for RYR1-related rhabdomyolysis

Eur J Neurol. 2016 Aug;23(8):e56-7. doi: 10.1111/ene.13051.

Authors

R S Scalco¹, N C Voermans², R J Piercy³, H Jungbluth⁴, R Quinlivan¹

Affiliations

¹ MRC Centre for Neuromuscular Diseases, UCL, London, UK.
² Department of Neurology, Radboud University Medical Centre, Nijmegen, The Netherlands.
³ Comparative Neuromuscular Diseases Laboratory, Royal Veterinary College, London.
⁴ Department of Clinical and Basic Neuroscience, IoPPN, King's College, UK.

PMID: 27431030
DOI: 10.1111/ene.13051

No abstract available

Keywords: RYR1; RYR1 dantrolene; RYR1 prophylaxis; RYR1 treatment; dantrolene; myoglobinuria; rhabdomyolysis prophylaxis; rhabdomyolysis treatment.

Publication types

Letter